Novartis
A new innovation center called the Biome and numerous internal efforts paint a picture of a digital-focused game plan.
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.
Medella pivots, Dutch company NovioSense's eyelid sensor shows promise, other efforts are academic.
Two more smart contact lenses, for presbyopia and cataract surgery recovery, are still in the works.
MobiHealthNews tracked investments, pilots, partnerships and app launches from major pharma companies during the quarter.
At DTx in Boston representatives of major pharma companies discussed opportunies of working with digital theraputics companies and what they wish the startups knew.
Novartis and Healint employed the Migraine Buddy app to track how migraines interact with anxiety and depression.
Novartis is looking to digital storytelling as a way to help cancer patients and their families.
A drug no longer needs to be a tangible object, according to panelist at the BIO 2018 convention in Boston.